Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Epidermal Growth Factor Receptor
100%
Epidermal Growth Factor Receptor Gene
100%
Lung Cancer Brain Metastases
100%
Gene mutant
100%
Brain Metastases
44%
Non-small Cell Lung Cancer Patients
33%
Clinical Data
22%
Overall Survival of Patients
22%
L858R mutation
22%
Better Prognosis
11%
Time Since Death
11%
Overall Survival
11%
Smoking History
11%
Log-rank Test
11%
Survival Analysis
11%
Median Survival Time
11%
Individualized Treatment
11%
Progression-free Survival
11%
Treatment Efficacy
11%
Survival Time
11%
Median Progression-free Survival
11%
Kaplan-Meier Survival
11%
EGFR mutation
11%
Exon Deletion
11%
Fujian
11%
Multiple Factor Analysis
11%
Pathological Type
11%
Treatment Progression
11%
Provincial Hospital
11%
Gene Detection
11%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Receptor Gene
100%
Case-Control Study
100%
Brain Metastasis
100%
Epidermal Growth Factor Receptor
100%
Overall Survival
27%
Progression Free Survival
18%
Time of Death
9%
Combination Therapy
9%
Log Rank Test
9%
Survival Time
9%
Survival Analysis
9%
Gene Mutation
9%
Median Survival Time
9%
Exon
9%
Factor Analysis
9%
Gene
9%
Biochemistry, Genetics and Molecular Biology
Case-Control Study
100%
Wild Type
100%
Receptor Gene
100%
Epidermal Growth Factor Receptor
100%
Overall Survival
27%
Progression Free Survival
18%
Exon
9%
Gene Mutation
9%
Survival Time
9%
Median Survival Time
9%
Nested Gene
9%
Factor Analysis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Case-Control Study
100%
Non Small Cell Lung Cancer
100%
Epidermal Growth Factor Receptor
100%
Brain Metastasis
100%
Overall Survival
27%
Progression Free Survival
18%
Combination Therapy
9%
Survival Time
9%
Median Survival Time
9%
Time of Death
9%